ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1725

CD14 Contributes to Increased Inflammation and Fibrogenesis in Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1201 Glomerular Diseases: Fibrosis and Extracellular Matrix

Authors

  • Yu, Jing, University of Hong Kong, Hong Kong, Hong Kong
  • Tai, Chi pang, University of Hong Kong, Hong Kong, Hong Kong
  • Yung, Susan, University of Hong Kong, Hong Kong, Hong Kong
  • Chan, Tak Mao Daniel, University of Hong Kong, Hong Kong, Hong Kong
Background

CD14 is a GPI-anchored membrane protein that serves as a pattern recognition receptor in the clinical setting of sepsis. CD14 transfers lipopolysaccharide (LPS) from the acute phase protein LPS-binding protein (LBP) to TLR-4/MD-2 complex, to initiate signal transduction and cytokines release. Serum CD14 level is increased in SLE patients, but little is known about its clinical significance or pathogenic role in lupus nephritis (LN).

Methods

Serum LPS and CD14 levels were determined in LN patients and healthy subjects using commercially available assays. CD14 expression in LN kidney biopsies was examined with cytochemical staining. CD14-overexpressing HK-2 cells were generated and the role of CD14 in inflammatory and fibrotic processes investigated.

Results

Serum LPS and CD14 levels were significantly higher in LN patients compared to healthy subjects (P<0.05, for both). Kidney biopsies from active LN patients showed increased CD14 expression, predominantly in proximal tubular epithelial cells, compared with normal kidney tissue. CD14 overexpression did not affect cell proliferation in HK-2 cells, but was associated with increased IL-6 secretion and fibronectin expression, by 26.73±4.63 fold and 3.19±2.28 fold respectively. Upon stimulation with either LPS or endotoxin-free TGF-β1, CD14-overexpressing HK-2 cells showed further augmentation of IL-6 secretion and fibronectin expression (P<0.05, for all). In contrast, HK-2 cells deficient in CD14 showed attenuated fibronectin expression upon LPS or TGF-β1 stimulation.

Conclusion

Our data show that active LN is accompanied by increased serum and renal tubular epithelial CD14 expression, and CD14 may contribute to LPS- or cytokine-dependent inflammatory and fibrotic processes in the setting of LN.

Funding

  • Government Support - Non-U.S.